Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuquan capsules for xerostomia in adults with type 2 diabetes mellitus
ChiCTR2300078590Phase 4Recruiting
- Sponsor
- Zhejiang Provincial Hospital of Traditional Chinese Medicine
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Yuquan in xerostomia and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Zhejiang Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Change from baseline in unstimulated whole saliva flow rate at week 12. Started Dec 2023; status: recruiting.
02
Drugs
Yuquan
03
Conditions
xerostomiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2300078590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078590.